4//SEC Filing
Gebski Christine 4
Accession 0000899243-23-007196
CIK 0000730272other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:28 PM ET
Size
11.2 KB
Accession
0000899243-23-007196
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Gebski Christine
See Remarks
Transactions
- Award
Common Stock
2023-03-02+3,467→ 32,660 total - Award
Common Stock
2023-03-03+375→ 33,035 total - Tax Payment
Common Stock
2023-03-03$188.00/sh−126$23,688→ 32,909 total - Award
Stock Option (Right to Buy)
2023-03-02+3,590→ 3,590 totalExercise: $180.48Exp: 2033-03-02→ Common Stock (3,590 underlying)
Footnotes (4)
- [F1]Ms. Gebski was awarded 3,467 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
- [F3]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.
- [F4]One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001849585
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:28 PM ET
- Size
- 11.2 KB